Next Article in Journal
Identification of Inherited Retinal Disease-Associated Genetic Variants in 11 Candidate Genes
Next Article in Special Issue
PGC1α: Friend or Foe in Cancer?
Previous Article in Journal
The Aging Mitochondria
Previous Article in Special Issue
Dualistic Role of BARD1 in Cancer
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Genes 2018, 9(1), 24;

NF-kappaB: Two Sides of the Same Coin

Laboratório de Célula-Tronco, Instituto Nacional de Câncer, 20230-130 Rio de Janeiro, RJ, Brazil
CAPES Foundation, Ministério da Educação, 70040-020 Brasília, DF, Brazil
These authors contributed equally to this article.
Author to whom correspondence should be addressed.
Received: 6 December 2017 / Revised: 2 January 2018 / Accepted: 5 January 2018 / Published: 9 January 2018
Full-Text   |   PDF [3817 KB, uploaded 9 January 2018]   |  


Nuclear Factor-kappa B (NF-κB) is a transcription factor family that regulates a large number of genes that are involved in important physiological processes, including survival, inflammation, and immune responses. More recently, constitutive expression of NF-κB has been associated with several types of cancer. In addition, microorganisms, such as viruses and bacteria, cooperate in the activation of NF-κB in tumors, confirming the multifactorial role of this transcription factor as a cancer driver. Recent reports have shown that the NF-κB signaling pathway should receive attention for the development of therapies. In addition to the direct effects of NF-κB in cancer cells, it might also impact immune cells that can both promote or prevent tumor development. Currently, with the rise of cancer immunotherapy, the link among immune cells, inflammation, and cancer is a major focus, and NF-κB could be an important regulator for the success of these therapies. This review discusses the contrasting roles of NF-κB as a regulator of pro- and antitumor processes and its potential as a therapeutic target. View Full-Text
Keywords: NF-kB; NF-kappaB; signaling; cancer; inflammation; immune response; treatment; therapy NF-kB; NF-kappaB; signaling; cancer; inflammation; immune response; treatment; therapy

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Pires, B.R.B.; Silva, R.C.M.C.; Ferreira, G.M.; Abdelhay, E. NF-kappaB: Two Sides of the Same Coin. Genes 2018, 9, 24.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top